Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arsenic Trioxide × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1 Leukemia 1

Interventions

pembrolizumab 526 Specimen Handling 513 Magnetic Resonance Spectroscopy 424 Carboplatin 341 Cyclophosphamide 320 Biopsy 297 Cisplatin 285 Paclitaxel 256 Nivolumab 242 Gemcitabine 226 Radiotherapy 223 Bevacizumab 187 Dexamethasone 185 fludarabine 179 venetoclax 174 Docetaxel 154 Oxaliplatin 151 atezolizumab 148 Fluorouracil 145 durvalumab 144 Pemetrexed 139 Rituximab 138 Capecitabine 135 Doxorubicin 126 Standard of Care 125 Radiation 125 Lenalidomide 122 Drug Therapy 118 Radiosurgery 116 Prednisone 115

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296445 2025-12-29

LATITUDE

SDK Therapeutics, Inc.

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡